ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 126728 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 126728; 2) Community: the network communities that were significantly associated with the response to NSC 126728; 3) Molecule: the relationships between components within communities and NSC 126728; 4) MDR: the compounds that were significantly associated with the NSC 126728.

NSC Compound Enrichment Correlation
NSC 677776 Null 0.000864214137711354 -0.21882787
NSC 697653 Null 0.000864214137711354 0.37718478
NSC 671316 Null 0.00094423800811012 0.55777459
NSC 723732 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one 0.00103112124545269 0.42094505
NSC 740 Methotrexate 0.00103112124545269 0.38272682
NSC 174121 Methotrexate Derivative 0.0016365323975257 0.38717451
NSC 625497 Antimony, dibromo(4-thiomorpholinecarbodithioato-S,S')-, (T-4)- 0.0016365323975257 0.52147184
NSC 694234 Null 0.0016365323975257 -0.29778533
NSC 763587 Null 0.0016365323975257 0.30921148
NSC 717842 Acetamide, 2-[[[2-(1,2-dihydro-2-oxo-3H-indol-3-ylidene)- 1,2-dihydro-3H-indol-3-ylidene]amino]oxy]-, (2Z)- 0.00172065213317242 0.29509935
Total:60  Current:2    [First] [Prev] [Next] [Last]